Shionogi   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Osaka Japan (1878)

Organization Overview

First Clinical Trial
2001
NCT00033215
First Marketed Drug
1967
mefenamic acid (ponstel)
First NDA Approval
1993
tacrine (cognex)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Shionogi | Shionogi Inc. | SHIONOGI INC